For nearly three decades, Grace John-Stewart, a professor of global health and epidemiology at the University of Washington School of Public Health, has devoted her career to improving HIV prevention and treatment.
Dear DGH community,
We are reaching out in support and solidarity as we reel from recent events. Today, supporters of President Trump violently entered the US Capitol and disrupted the counting of certified electoral votes, encouraged by the President’s false claims of election fraud. The disruption of our democratic process in Washington, DC and the violence we are witnessing are deeply disturbing. We recognize that these scenes may be distressing, especially to members of our community who have lived through coups and civil unrest.
Even partial protection of one dose could be enough to slow the spread of the virus, the UW Medicine researchers argue in a paper.
MEDIA CONTACT: Susan Gregg - 206.616.6730, sghanson@uw.edu
Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine.
By Helen Taylor, Bobby Righi and Jonis Davis, Special to The Seattle Times
Volunteer enrollment begins for Phase III clinical trial that will determine the efficacy of Novavax vaccine candidate.
UW Medicine investigators are starting volunteer enrollment for an investigational COVID-19 vaccine clinical trial. The Phase III study will examine whether the Novavax vaccine candidate can protect against SARS-CoV-2, the coronavirus responsible for COVID-19.
As states wrestle with whether to prioritize essential workers or the elderly, Tennessee is setting aside shots for especially vulnerable areas.
By Isaac Stanley-Becker and Lena H. SunDec. 18, 2020 at 10:00 a.m. PST
The U.S. Food and Drug Administration (FDA) has granted emergency use for two new coronavirus vaccines, one developed by the drug company Pfizer and the biotech company BioNTech and the other by the biotech company ModernaTX. Both are mRNA vaccines and have similar structure.
Both vaccines contain modified mRNA that provides the instructions for the synthesis of the SARS-CoV-2 spike glycoprotein antigen. Its mRNA is enveloped in lipid nanoparticles (LNPs) to prevent degradation and enhance uptake into cells.
This updated in-depth summary (previously released on December 21, 2020) is issued in response to new information that we received about updated definitions of aerosol particles that show that larger respiratory particles (<100 μm) can remain airborne for extended periods, and that in enclosed areas with poor ventilation, these aerosols containing infectious SARS-CoV-2 can spread beyond 6 feet and build up in a room. We apologize for not including this information in the earlier version of this summary.
By Jacqueline Howard and Jen Christensen, CNN
(CNN)Vaccine advisers to the US Centers for Disease Control and Prevention voted 13-1 on Sunday to recommend that both older adults, ages 75 and older, and "frontline essential workers" including first responders be next in line to receive Covid-19 vaccines.
That would put those people in "Phase 1b" of allocating the vaccine nationwide.
Dr. Paul Drain, Associate Professor of Global Health and Medicine, and Dr. Matthew Thompson (Family Medicine) will lead UW’s arm of the RADx-UP program, “Protecting Our Community: A Pragmatic Randomized Trial of Home-based COVID Testing with American Indian and Latino Communities”.